• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

This Report Analyzes the Prevalent Stem Cell Technologies and the Therapeutic Areas in Which Stem Cells Find Applications

Posted on: Wednesday, 5 March 2008, 09:01 CST

Research and Markets (http://www.researchandmarkets.com/reports/c84980) has announced the addition of "Stem Cell Research 2008" to their offering.

The study provides a market insight into the ever progressing and debatable market of Stem Cell Research segmented by type, technology and therapeutic area. Stem Cells by Type are further classified into Adult Stem Cells, Embryonic Stem Cells, and Cord Blood Stem Cells. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, Cell Based Genomics, Xenotransplantation, Cord Blood Banking, and Other. The Therapeutic applications of Stem Cell Research are analyzed by area into Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes, Dermatology and Other. Projections and estimates are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific and Rest of World.

The science of stem cells is leading to evolution of cell-based therapies referred to as reparative or regenerative medicine for the treatment of diseases. The ongoing research on stem cells indicates the replenishment of damaged cells by healthy cells in adult organism and the origin of an organism through a single cell. Stem cell science is predicted to be the most promising field in Biology though it has its own share of queries and controversies.

This report analyzes the prevalent stem cell technologies and the therapeutic areas in which stem cells find their applications. Global stem cells market is segmented by - Stem Cell Types into Adult Stem Cells, Embryonic Stem Cells and Cord Blood Stem Cells; by Therapeutic Area into Neurological, Bon and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other; and by Technology into SC Transplantation, CB Genomics, Xenotransplantation, Cord Blood Banking and Other.

Global Stem Cells market is projected to reach about US$ 32.3 billion by 2012. Stem cell research has picked up pace like never before now. The technology is leading to a new kind of cell-based medicine that is regenerative in nature. However, practicality and ethics dominate the ever controversial subject. Hence, it may take some more time, before a proper worldwide consensus emerges on the usage and procedures of stem cell research. While some countries approve, some oppose. Stem cell research is most likely to gather pace in countries with less regulatory controls. Of all the countries, China has the most favourable environment for research. The UK too has a strong research presence. The United States is the leader in stem cell research. However, the government controls the grants for research but places no restrictions on funds from private, state, or local government resources.

Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. The US is the leader followed by the European and Asia-Pacific regions. With government regulations being amended in several countries, stem cell research is expected to pick up pace rapidly in the next few years. The potential of stem cell research -- both medically and economically, is leading to huge investments by biotechnology companies, pharmaceutical companies and governments too.

Contents:

I. Scope And Methodology

Ii. Report Synopsis

Iii. Product/Technology Research

Iv. Market Dynamics

V. Corporate Directory

For more information visit http://www.researchandmarkets.com/reports/c84980

Source: Business Wire

More News in this Category